Inhibikase Therapeutics, Inc. - IKT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | — | A | A | 155,000.0 | 0.0 | 0.0 | 155,000.0 | View | |
| Jun 30, 2026 | — | A | A | 155,000.0 | 0.0 | 0.0 | 155,000.0 | View | |
| Jun 30, 2026 | — | A | A | 155,000.0 | 0.0 | 0.0 | 155,000.0 | View | |
| Jun 30, 2026 | — | A | A | 155,000.0 | 0.0 | 0.0 | 155,000.0 | View | |
| Jun 30, 2026 | — | A | A | 155,000.0 | 0.0 | 0.0 | 155,000.0 | View | |
| Jun 30, 2026 | — | A | A | 155,000.0 | 0.0 | 0.0 | 155,000.0 | View | |
| Feb 24, 2026 | — | D | D | 19,089.0 | 0.0 | 0.0 | 38,176.0 | View | |
| Feb 24, 2026 | President & Head of R&D | D | D | 338,282.0 | 0.0 | 0.0 | 676,564.0 | View | |
| Feb 24, 2026 | — | D | D | 255,299.0 | 0.0 | 0.0 | 510,596.0 | View |